<div class="embed-container"><iframe src="https://www.youtube.com/embed/76_lgvaIxTQ" frameborder="0" allowfullscreen=""></iframe></div> <p>The Cure Starts Now Foundation and their partners The DIPG/DMG Collaborative today announced a $1 million research grant to support a joint project led by <strong>Seattle Children’s Hospital and St. Jude Children’s Research Hospital</strong>. The award, the foundation’s “Big Fat Grant,” will accelerate development of promising new strategies to treat <a href="https://dipg.org/facts/what-is-dmg/" title="What is DMG">diffuse midline glioma (DMG)</a>, one of the most aggressive childhood brain cancers. </p> <p>This is the second year in a row the foundation has awarded this grant, a direct result of the generosity of its donors. This is the fourth largest grant awarded by the charity in its 18-year history. This landmark project builds on an ongoing clinical trial using B7-H3 CAR T cell therapy for DMG. </p> <p>With this new funding, researchers will explore ways to improve the tumor immune microenvironment, preparing it to better respond to treatment. By testing pre-treatment strategies such as radiation and laboratory-validated approaches, the team aims to create conditions that allow CAR T cells to work more effectively and deliver stronger, longer-lasting responses.</p> <blockquote>“The $1,000,000 Big Fat Grant is all about big ideas,” said Brooke Desserich, Co-Founder and Executive Director of The Cure Starts Now. “By funding this innovative work, we’re helping to push the boundaries of what is possible for children facing DMG, while laying a foundation for breakthroughs across all brain cancers.”</blockquote> <p>The Cure Starts Now has raised over <strong>$37.5 million</strong> in cancer research and support across 80 institutions worldwide in tandem with the DIPG/DMG Collaborative. This latest grant reflects the foundation’s commitment to driving forward bold, collaborative research with the potential to unlock the universal cure for cancer.</p>
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Family-Funded Research Driving Global Hope for Kids with Cancer | 0 | 8.9 | 12-05-2026 |
| 2 | A More Precise CAR T-Cell Approach for DIPG and DMG | 0 | 12.46 | 22-01-2026 |
| 3 | Après des années de combat, le financement public alloué à la recherche sur les cancers pédiatriques porté à 20 M€/an | 0 | 7.38 | 11-02-2026 |
| 4 | Brain tumor vaccine links mutation targeting to eight-year survival gains | 7 | 8 | 06-07-2026 |
| 5 | Москва выделила гранты на инновационные методы лечения онкозаболеваний у детей | 0 | 0 | 07-03-2025 |
| 6 | Cancer research in Alberta gets $35 million boost | 7 | 8 | 06-07-2026 |
| 7 | Кабмин направит Минздраву более 17 млрд рублей на лечение детей с тяжелыми заболеваниями | 0 | 0 | 30-06-2021 |
| 8 | Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma | 0 | 5 | 09-03-2026 |
| 9 | В Москве выделили 462 млн руб. на лечение онкобольных детей по инновационным методикам | 0 | 0 | 20-01-2022 |
| 10 | First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients | 7 | 8 | 10-07-2026 |